11 November 2025
John Armstrong
Via email:
[email address]
Tēnā koe John
Request for information and partial transfer of your request: Kostaive vaccine
Thank you for your request dated 4 November 2025 under the Official Information Act 1982
(OIA) for information relating to Kostaive. You requested:
Dear Pharmaceutical Management Agency,
I seek information for Kostaive self-amplifying mRNA as listed on pg 10, section 8 -
Market Analysis, in a prior response received from Pharmac, reference
H2025072586, Procurement Plan for Covid-19 vaccine RFP.
https://aus01.safelinks.protection.outlook.com/?url=https%3A%2F%2Ffyi.org.nz%2Fr
equest%2F32255-supply-agreement-with-pfizer-for-supply-of-cominarty-brand-of-
covid-19-vaccine%23incoming-
131690&data=05%7C02%7CMinisterials%40Pharmac.govt.nz%7Cf4d6de67abf74c6
19d7608de1bdeddb6%7C2a64c3b0239f425bb657b2642c95b456%7C0%7C0%7C63
8978841187978203%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydW
UsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%
7C0%7C%7C%7C&sdata=385js%2BJ%2Fp%2B%2FGQyxDETbl1T6uwsH%2F62dw
dzcwYSxnky0%3D&reserved=0
It states: "Pharmac staff are aware of four Covid-19 vaccines that may be available in
New Zealand". These were then listed as follows:
1/ Kostaive (Seqirus) self-amplifying mRNA.
2/ Spikevax (Moderna) mRNA
3/ Comirnaty (Pfizer) mRNA
4/ Nuvaxovid (Biocelect /Novavax) attenuated protein subunit
Q1/ Is Kostaive currently in circulation and being administered in NZ?
Q2/ Has Kostaive been administered in the past in NZ, please provide dates?
Q3/ Please supply documentation of clinical trials for Kostaive in NZ?
Q4/ Please supply Medsafe's approval and consent for distribution of Kostaive in NZ.
2025-26-099
Our response to Q1 and Q2
Q1: Is Kostaive currently in circulation and being administered in NZ?
No, it is not currently in circulation or being administered in New Zealand.
Q2: Has Kostaive been administered in the past in NZ, please provide dates?
Kostaive has never been supplied or administered in New Zealand.
Partial transfer of your request
Pharmac does not hold information relating to Q3 and Q4 of your request; however, I have
been advised that this information is held by the Ministry of Health. For this reason, I have
decided to partially transfer your request to Ministry of Health under section 14(b)(ii).
Q3/ Please supply documentation of clinical trials for Kostaive in NZ?
Q4/ Please supply Medsafe's approval and consent for distribution of Kostaive in NZ.
You can expect a response from Ministry of Health in due course. They can be contacted at:
[email address]
We trust that this information answers your queries. Please note, you have the right to make
a complaint to the Ombudsman about our response to your OIA, under section 28(3) of the
OIA. Details of
how to make a complaint are on the Ombudsman’s website.
To make information more freely available, we publish selected OIA responses (excluding
personal details) on our website. Please get in touch with us if you have any questions about
this.
Nāku noa, nā
Oliver Whitehead
Team Leader, Government Services
qA77661
2
